Specificity and Breadth of the Neutralizing Antibody Response to a Live-Attenuated Tetravalent Dengue Vaccine

被引：9
|
作者：
DeMaso, Christina R. [1 ]
Karwal, Lovkesh [1 ]
Zahralban-Steele, Melissa [1 ]
Dominguez, David [1 ]
Springer, Zhang-Li [1 ]
Kaiser, Maima [1 ]
Palani, Sunil [1 ]
Rindfleisch, Tim [1 ]
Bohning, Kelly [1 ]
Hather, Greg [1 ]
Das, Subash [1 ]
Sharma, Mayuri [1 ]
Dean, Hansi J. [1 ]
机构：
[1] Takeda Pharmaceut USA, Vaccines Business Unit, Cambridge, MA USA
来源：
JOURNAL OF INFECTIOUS DISEASES | 2022年 / 226卷 / 11期
关键词：
dengue vaccine; dengue virus; neutralizing antibody response; TAK-003; type-specific; IMMUNOGENICITY; INFECTIONS; SAFETY; ADULTS;
D O I：
10.1093/infdis/jiac272
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Background An effective dengue vaccine should ideally induce broadly neutralizing antibody (nAb) responses against all 4 dengue virus (DENV) serotypes. Methods We characterized the specificity and breadth of the nAb response to TAK-003, a live-attenuated tetravalent dengue vaccine, in serum samples from phase 2 and 3 clinical trials. Results Microneutralization tests using postvaccination serum showed comparable neutralization against diverse DENV-1-4 genotypes. Reporter virus particle neutralization assays after depletion of anti-DENV-2 nAbs demonstrated that the nAb response to DENV-1, -3, and -4 comprises both type-specific (TS) and cross-reactive (CR) nAbs. Conclusions Therefore, TAK-003 induces broad tetravalent TS and CR nAb responses. We characterized the specificity and breadth of neutralizing antibody (nAb) response to a live-attenuated tetravalent dengue vaccine candidate and found that the nAb response comprised both type-specific and cross-reactive nAbs, with comparable neutralization of diverse dengue genotypes.
引用
收藏
页码：1959 / 1963
页数：5
相关论文
共 50 条
  • [1] DISSECTING THE SPECIFICITY OF THE NEUTRALIZING ANTIBODY RESPONSE TO A LIVE ATTENUATED TETRAVALENT DENGUE VACCINE (TDV) CANDIDATE
    Henein, Sandra
    Swanstrom, Jesica
    Widman, Douglas G.
    Stinchcomb, Dan T.
    Dean, Hansi
    Osorio, Jorge E.
    Partidos, Charalambos D.
    Baric, Ralph S.
    de Silva, Aravinda
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2015, 93 (04): : 165 - 165
  • [2] Delineating the serotype-specific neutralizing antibody response to a live attenuated tetravalent dengue vaccine
    Gromowski, Gregory D.
    Henein, Sandra
    Kannadka, Chandrika B.
    Barvir, David A.
    Thomas, Stephen J.
    de Silva, Aravinda M.
    Jarman, Richard G.
    [J]. VACCINE, 2018, 36 (18) : 2403 - 2410
  • [3] Magnitude and Functionality of the NS1-Specific Antibody Response Elicited by a Live-Attenuated Tetravalent Dengue Vaccine Candidate
    Sharma, Mayuri
    Glasner, Dustin R.
    Watkins, Heather
    Puerta-Guardo, Henry
    Kassa, Yoseph
    Egan, Michael A.
    Dean, Hansi
    Harris, Eva
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2020, 221 (06): : 867 - 877
  • [4] A rapid immunization strategy with a live-attenuated tetravalent dengue vaccine elicits protective neutralizing antibody responses in non-human primates
    Ambuel, Yuping
    Young, Ginger
    Brewoo, Joseph N.
    Paykel, Joanna
    Weisgrau, Kim L.
    Rakasz, Eva G.
    Haller, Aurelia A.
    Royals, Michael
    Huang, Claire Y. -H.
    Capuano, Saverio
    Stinchcomb, Dan T.
    Partidos, Charalambos D.
    Osorio, Jorge E.
    [J]. FRONTIERS IN IMMUNOLOGY, 2014, 5 : 1 - 8
  • [5] Live attenuated tetravalent dengue vaccine
    Bhamarapravati, N
    Sutee, Y
    [J]. VACCINE, 2000, 18 : 44 - 47
  • [6] Phase I trial of 16 formulations of a tetravalent live-attenuated dengue vaccine
    Edelman, R
    Wasserman, SS
    Bodison, SA
    Putnak, RJ
    Eckels, KH
    Tang, D
    Kanesa-Thasan, N
    Vaughn, DW
    Innis, BL
    Sun, W
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2003, 69 (06): : 48 - 60
  • [7] Vaccination of human volunteers with monovalent and tetravalent live-attenuated dengue vaccine candidates
    Sun, W
    Edelman, R
    Kanesa-Thasan, N
    Eckels, KH
    Putnak, JR
    King, AD
    Houng, HS
    Tang, D
    Scherer, JM
    Hoke, CH
    Innis, BL
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2003, 69 (06): : 24 - 31
  • [8] Safety and immunogenicity of a tetravalent live-attenuated dengue vaccine in flavivirus naive children
    Simasathien, Sriluck
    Thomas, Stephen J.
    Watanaveeradej, Veerachai
    Nisalak, Ananda
    Barberousse, Celia
    Innis, Bruce L.
    Sun, Wellington
    Putnak, J. Robert
    Eckels, Kenneth H.
    Hutagalung, Yanee
    Gibbons, Robert V.
    Zhang, Chunlin
    De La Barrera, Rafael
    Jarman, Richard G.
    Chawachalasai, Wipa
    Mammen, Mammen P., Jr.
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2008, 78 (03): : 426 - 433
  • [9] QUALITY OF THE ANTIBODY RESPONSE INDUCED BY A LIVE ATTENUATED TETRAVALENT DENGUE VACCINE IN NAIVE AND DENGUE EXPOSED INDIVIDUALS
    White, Laura
    Stoops, Mark
    Swanstrom, Jesica
    Young, Ellen
    Mukherjee, Swati
    Dean, Hansi
    Baric, Ralph
    de Silva, Aravinda
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2018, 99 (04): : 506 - 507
  • [10] Recombinant, live-attenuated tetravalent dengue virus vaccine formulations induce a balanced, broad, and protective neutralizing antibody response against each of the four serotypes in rhesus monkeys
    Blaney, JE
    Matro, JM
    Murphy, BR
    Whitehead, SS
    [J]. JOURNAL OF VIROLOGY, 2005, 79 (09) : 5516 - 5528
12345